Infectious Diseases

Nucleic acid-based detection of infectious disease agents is rapidly becoming the gold standard in clinical microbiology diagnostics as it offers unparalleled sensitivity and specificity as compared to current detection methods.  Nanosphere has several tests under development that will leverage our patented gold nanoparticle probe technology to enable rapid, multiplex detection of amplified and non-amplified infectious disease targets in a novel, sample-to-result, random access testing instrument that will minimize user hands on time.  To learn more about Nanosphere's first infectious disease test, the Verigene^® Respiratory Virus Nucleic Acid Test_SP (RVNAT_SP), please click here.